INOTEK PHARMACEUTICALS CORP
INOTEK PHARMACEUTICALS CORP (ITEK) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 29 transactions totaling $26.7M, demonstrating a bullish sentiment with $26.7M in net insider flow. The most recent transaction on Sep 14, 2017 involved a transaction of 12,500 shares valued at $0.
ITEK Insider Activity Summary
Who Is Buying ITEK Stock?
No significant insider buying has been recorded for ITEK in the recent period.
Who Is Selling ITEK Stock?
No significant insider selling has been recorded for ITEK in the recent period.
Is INOTEK PHARMACEUTICALS CORP Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ITEK is bullish with an Insider Alignment Score of 100/100 and a net flow of $26.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ITEK Frequently Asked Questions
Understanding ITEK Insider Activity
Insider trading at INOTEK PHARMACEUTICALS CORP (ITEK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading ITEK stock, having executed 29 transactions in the past 90 days. The most active insider is Joshua Ruch (Executive), who has made 3 transactions totaling $5.7M.
Related Tools
Track INOTEK PHARMACEUTICALS CORP Insider Activity
Get notified when executives and directors at ITEK file new Form 4 transactions